Institutional Ownership Cerevel Therapeutics Holdings, Inc. (CERE)
This table provides information about the institutional ownership of Cerevel Therapeutics Holdings, Inc. (CERE). We have compiled data on the 9 institutions that hold shares in the stock, with a total of 5.01 Million shares, which have been reported (via 13F filing form) to have a value of $0.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
3,560,931
shares
|
$0
0.0% of portfolio
|
Q2 2024
Reduced 34.65%
|
|
|
Segantii Capital Management LTD
|
May 14, 2024 Q1 2024 |
1,143,426
shares
|
$0
5.99% of portfolio
|
Q1 2024
Added 92.33%
|
|
|
Tekla Capital Management LLC
|
Aug 10, 2023 Q2 2023 |
176,483
shares
|
$0
0.22% of portfolio
|
Q3 2022
Added 100.16%
|
|
|
Credit Suisse Ag
Zurich, V8 |
May 10, 2024 Q1 2024 |
111,634
shares
|
$0
0.0% of portfolio
|
Q1 2024
Reduced 36.03%
|
|
|
Kellner Capital, LLC
New York, NY |
Feb 07, 2024 Q4 2023 |
20,300
shares
|
$0
1.55% of portfolio
|
Q4 2023
New holding
|
|
|
Ifp Advisors, Inc
|
Jul 30, 2024 Q2 2024 |
764
shares
|
$0
0.0% of portfolio
|
Q1 2024
New holding
|
|
|
Ronald Blue Trust, Inc.
Brentwood, TN |
Oct 17, 2024 Q3 2024 |
126
shares
|
$0
0.0% of portfolio
|
Q3 2024
Added 5.88%
|
|
|
Benjamin F. Edwards & Company, Inc.
St. Louis, MO |
Aug 12, 2024 Q2 2024 |
80
shares
|
$0
0.0% of portfolio
|
Q2 2024
Reduced 56.04%
|